NFL Biosciences SA

12/19/2023 | Press release | Distributed by Public on 12/19/2023 01:06

NFL BIOSCIENCES: PRE-IND APPLICATION FILED WITH THE FDA IN THE UNITED STATES FOR NFL-301, INDICATED FOR REDUCING ALCOHOL CONSUMPTION

NFL BIOSCIENCES: PRE-IND APPLICATION FILED WITH THE FDA IN THE UNITED STATES FOR NFL-301, INDICATED FOR REDUCING ALCOHOL CONSUMPTION

19 Dec 2023 08:00 CET

Subscribe

Issuer

NFL BIOSCIENCES S.A.

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

Appendix

Source

NFL BIOSCIENCES

Provider

Les Echos

Company Name

NFL BIOSCIENCES S.A.

ISIN

FR0014003XT0

Symbol

ALNFL

Market

Euronext Growth